Loading clinical trials...
Loading clinical trials...
Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans: Myonuclear Addition, Hypertrophy and Myocellular Reprogramming
The purpose of the project is investigate muscle memory and underlying mechanisms in humans following resistance training and use of the anabolic substance clenbuterol.
Age
18 - 40 years
Sex
ALL
Healthy Volunteers
Yes
August Krogh Building
Copenhagen, Denmark
Start Date
February 1, 2023
Primary Completion Date
December 1, 2024
Completion Date
August 1, 2025
Last Updated
January 20, 2023
60
ESTIMATED participants
Clenbuterol
DRUG
Placebo
DRUG
Lead Sponsor
Morten Hostrup, PhD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions